Brown‐Vialetto‐Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment
Open Access
- 26 November 2010
- journal article
- case report
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 34 (1), 159-164
- https://doi.org/10.1007/s10545-010-9242-z
Abstract
We report on three patients (two siblings and one unrelated) presenting in infancy with progressive muscle weakness and paralysis of the diaphragm. Metabolic studies revealed a profile of plasma acylcarnitines and urine organic acids suggestive of a mild form of the multiple acyl‐CoA dehydrogenation defect (MADD, ethylmalonic/adipic acid syndrome). Subsequently, a profound flavin deficiency in spite of a normal dietary riboflavin intake was established in the plasma of all three children, suggesting a riboflavin transporter defect. Genetic analysis of these patients demonstrated mutations in the C20orf54 gene which encodes the human homolog of a rat riboflavin transporter. This gene was recently implicated in the Brown‐Vialetto‐Van Laere syndrome, a rare neurological disorder which may either present in infancy with neurological deterioration with hypotonia, respiratory insufficiency and early death, or later in life with deafness and progressive ponto‐bulbar palsy. Supplementation of riboflavin rapidly improved the clinical symptoms as well as the biochemical abnormalities in our patients, demonstrating that high dose riboflavin is a potential treatment for the Brown‐Vialetto‐Van Laere syndrome as well as for the Fazio Londe syndrome which is considered to be the same disease entity without the deafness.Keywords
This publication has 16 references indexed in Scilit:
- Identification of the human mitochondrial FAD transporter and its potential role in multiple acyl-CoA dehydrogenase deficiencyMolecular Genetics and Metabolism, 2005
- Brown–Vialetto–Van Laere syndrome; variability in age at onset and disease progression highlighting the phenotypic overlap with Fazio-Londe diseaseBrain & Development, 2005
- Riboflavin (vitamin B-2) and healthThe American Journal of Clinical Nutrition, 2003
- D,L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD)The Lancet, 2003
- Analysis of riboflavin and riboflavin cofactor levels in plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 2000
- Quantitative acylcarnitine profiling in fibroblasts using [U-13C] palmitic acid: an improved tool for the diagnosis of fatty acid oxidation defectsClinica Chimica Acta; International Journal of Clinical Chemistry, 1999
- Late‐onset riboflavin‐responsive myopathy with combined multiple acyl coenzyme A dehydrogenase and respiratory chain deficiencyNeurology, 1994
- Clinical and Biochemical Variation and Family Studies in the Multiple Acyl-CoA Dehydrogenation DisordersPediatric Research, 1987
- Organic aciduria in the riboflavin-deficient ratThe American Journal of Clinical Nutrition, 1981
- NEW DEFECT IN FATTY-ACID METABOLISM WITH HYPOGLYCÆMIA AND ORGANIC ACIDURIAThe Lancet, 1977